OncoC4
Latest round
- Series B
Last raised
- Oct 2025
Total raised
- $50M
Investors
- 4
About OncoC4
Founded in 2020 and headquartered in Rockville, US, OncoC4, Inc. specializes in oncology solutions.OncoC4 specializes in developing next-generation therapies targeting hard-to-treat cancers and Alzheimer’s disease. Their primary offerings include pioneering treatments that leverage innate and adaptive immune checkpoints, specifically focusing on CTLA-4, CD24, and Siglec signaling pathways. These therapeutics aim to enhance immune response against cancer cells while minimizing adverse effects associated with traditional therapies. Their portfolio encompasses monoclonal antibodies (mAbs), bispecific antibodies (BsAbs), antibody-drug conjugates (ADCs), and CAR T-cell therapies. OncoC4's products are designed for use in clinical settings, primarily targeting healthcare institutions and specialists involved in oncology and immunotherapy.OncoC4 generates revenue through partnerships and collaborations with pharmaceutical companies, research institutions, and healthcare providers. Their business model is primarily B2B, focusing on strategic alliances for clinical development and commercialization of their innovative therapies. Revenue streams include milestone payments, licensing agreements, and royalties derived from product sales. The company’s flagship products, such as their PD-1/VEGF bispecific program and CTLA-4 antibody therapies, are central to their revenue generation, as they are positioned to disrupt existing treatment paradigms for immunotherapy-resistant cancers.OncoC4, Inc. plans to expand its product offerings, focusing on new therapies aimed at enhancing treatment efficacy for oncology and Alzheimer's disease. The upcoming products are targeted for launch within the next 18 months.00 mn to support these initiatives and enhance its research and development capabilities.
Who invested in OncoC4
4 investors across 1 round
See all investors in OncoC4
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series B
Oct 2, 2025
Amount
$50M
Investors
Questions about OncoC4
Who invested in OncoC4?
OncoC4 has 4 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has OncoC4 raised?
OncoC4 has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did OncoC4 last raise money?
OncoC4's most recent round on record is a Series B, in Oct 2025.
What does OncoC4 do?
Founded in 2020 and headquartered in Rockville, US, OncoC4, Inc.
Where is OncoC4 headquartered?
OncoC4 is headquartered in Rockville, US.
Which VCs invest in companies like OncoC4?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at OncoC4's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like OncoC4? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.